Cleared Traditional

K944731 - ABBOTT IMX 2 ANALYZER

K944731 is an FDA 510(k) clearance for ABBOTT IMX 2 ANALYZER, manufactured by Abbott Laboratories. The device is a Class 1 Toxicology device with product code JJI cleared through the Traditional 510(k) pathway after a 98-day FDA review.

K944731 · Abbott Laboratories · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1994
Decision
98d
Days
Class 1
Risk

K944731 is an FDA 510(k) clearance for the ABBOTT IMX 2 ANALYZER. Classified as Analyzer, Enzyme, For Clinical Use (product code JJI), Class I - General Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on December 19, 1994 after a review of 98 days - within the typical 510(k) review window.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.2500 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Toxicology review framework, consistent with the majority of Class II 510(k) submissions.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K944731

510(k) Number K944731 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 12, 1994
Decision Date December 19, 1994
Days to Decision 98 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
11d slower than avg
Panel avg: 87d · This submission: 98d
Pathway characteristics
Predicate-based equivalence.

JJI Device Classification - Class 1, General Controls

Product Code JJI Analyzer, Enzyme, For Clinical Use
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.2500
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJI Analyzer, Enzyme, For Clinical Use

Devices cleared under the same product code (JJI) and FDA review panel - the closest regulatory comparables to K944731.
CODA AUTOMATED EIA ANALYZER
K972024 · Bio-Rad · Jul 1997
ABBOTT IMX2 ANALYER
K931970 · Abbott Laboratories · Jun 1993
RADIAS AUTOMATED IMMUNOASSAY SYSTEM
K930898 · Bio-Rad · Apr 1993
QUICKRATE REACTION RATE ANALYZER
K780972 · Olympus Corp. · Aug 1978
LDH/NADH,LDH/NADH, NAD & NAD DIAPHORASE
K770401 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Apr 1977